Petrus Trust Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-639
Closed -$249K – 279
2025
Q2
$249K Sell
639
-346
-35% -$139K 0.03% 395
2025
Q1
$428K Sell
985
-1,699
-63% -$682K 0.04% 266
2024
Q4
$990K Buy
2,684
+1,778
+196% +$744K 0.1% 38
2024
Q3
$471K Buy
+906
New +$484K 0.05% 255
2024
Q2
– Sell
-622
Closed -$323K – 626
2024
Q1
$323K Sell
622
-907
-59% -$451K 0.03% 405
2023
Q4
$721K Sell
1,529
-951
-38% -$440K 0.07% 102
2023
Q3
$1.08M Buy
2,480
+637
+35% +$289K 0.12% 34
2023
Q2
$819K Buy
1,843
+705
+62% +$325K 0.09% 40
2023
Q1
$523K Buy
1,138
+531
+87% +$253K 0.06% 76
2022
Q4
$311K Buy
+607
New +$308K 0.04% 251
2020
Q1
– Sell
-926
Closed -$280K – 214
2019
Q4
$280K Sell
926
-270
-23% -$74.3K 0.04% 142
2019
Q3
$287K Buy
+1,196
New +$328K 0.05% 106
2016
Q4
– Sell
-1,679
Closed -$210K – 199
2016
Q3
$210K Buy
+1,679
New +$217K 0.05% 136

Other funds holding ELV

Petrus Trust Company's ELV Position: Q3 2025 in Review

Petrus Trust Company sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 639 shares — an estimated $249K sold.

Petrus Trust Company first reported a position in ELV in Q3 2016 and held it in 13 quarters. The position peaked at $1.08M in Q3 2023. 1,512 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Petrus Trust Company reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Petrus Trust Company sold 639 Elevance Health shares in Q3 2025, an estimated $249K.
  • Petrus Trust Company first reported a position in Elevance Health in Q3 2016 and held it in 13 quarters.
  • Petrus Trust Company's Elevance Health position peaked at $1.08M in Q3 2023.
  • 1,512 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.